CpG oligonucleotides are effective in immunotherapy of a minimal residual tumour disease after surgery or chemotherapy in a murine model of MHC class I deficient, HPV¨16-associated tumours

REINIŠ, Milan, ŠÍMOVÁ, Jana, INDROVÁ, Marie, BIEBLOVÁ, Jana, JANDLOVÁ, Táňa, BUBENÍK, Jan. CpG oligonucleotides are effective in immunotherapy of a minimal residual tumour disease after surgery or chemotherapy in a murine model of MHC class I deficient, HPV¨16-associated tumours. In: Abstract Book. Praha: MSD, 2006, s. 336.